Report overview
Jet lag is a sleep disorder that occurs when the body's biological clock does not correspond to local time. This is common when traveling across different time zones.Melatonin is a natural hormone made by the body's pineal gland that helps regulate the sleep-wake cycle.
This report contains market size and forecasts of Jet Lag Therapy Pharmaceuticals in Global, including the following market information:
Global Jet Lag Therapy Pharmaceuticals Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Jet Lag Therapy Pharmaceuticals market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Rx Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Jet Lag Therapy Pharmaceuticals include Teva, Natrol/Aurobindo, Pharmavite, Nature's Bounty, Jameison, Pfizer and Now Food, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Jet Lag Therapy Pharmaceuticals companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Jet Lag Therapy Pharmaceuticals Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Jet Lag Therapy Pharmaceuticals Market Segment Percentages, by Type, 2021 (%)
Rx
OTC
Global Jet Lag Therapy Pharmaceuticals Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Jet Lag Therapy Pharmaceuticals Market Segment Percentages, by Application, 2021 (%)
Business Travelers
Cabin Crew
Athletes
Seasonal Travelers
Others
Global Jet Lag Therapy Pharmaceuticals Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Jet Lag Therapy Pharmaceuticals Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Jet Lag Therapy Pharmaceuticals revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Jet Lag Therapy Pharmaceuticals revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Teva
Natrol/Aurobindo
Pharmavite
Nature's Bounty
Jameison
Pfizer
Now Food
